Skip to main content

Table 2 Hypothetical immunotherapy protocol simulated

From: Enhancing dendritic cell immunotherapy for melanoma using a simple mathematical model

Protocol DC Inj. Interval Number of % of DCs % of Decrease Erad
  doses (hours) doses    
2 102 168 3 50 12.61 no
3 103 168 3 50 19.92 no
4 104 168 3 50 20.79 no
5 105 168 3 50 20.95 no
6 106 168 3 50 68.65 no
7 107 168 3 50 88.69 yes
8 108 168 3 50 91.68 yes
9 109 168 3 50 91.68 yes
10 106 48 8 50 85.97 yes
11 106 72 5 50 83.70 yes
12 106 96 4 50 81.40 yes
13 106 120 3 50 76.05 no
14 106 144 3 50 76.72 no
15 106 192 2 50 37.12 no
16 106 216 2 50 33.11 no
17 106 168 3 100 80 yes
18 106 168 3 80 77.58 yes
19 106 168 3 60 73.05 no
20 106 168 3 40 60.33 no
21 106 168 3 20 22.16 no
  1. Inj. Interval Injection Interval, Erad Eradication, % of DCs Percentage of DCs that arrive at the beginning of the immune response.